Navigation Links
PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
Date:11/2/2009

INCLINE VILLAGE, Nev., Nov. 2 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it closed on its previously disclosed $300 million securitization transaction intended to monetize certain of its antibody humanization patents and royalties. Morgan Stanley & Co. Incorporated acted as sole initial purchaser for the securitization.

Under the terms of the securitization transaction, PDL sold to QHP Royalty Sub LLC ("QHP"), a newly-formed wholly-owned subsidiary of PDL, certain rights under its non-exclusive license agreements with Genentech, Inc., a wholly-owned subsidiary of Roche Holding, Ltd., including the right to receive 60% of the royalties from sales of Avastin® (Bevacizumab), Herceptin® (Trastuzumab), Lucentis® (Ranibizumab) and Xolair® (Omalizumab) and from sales of future products, if any, for which Genentech may take a license under the related agreements with Genentech.

QHP issued $300 million in aggregate principal amount of its QHP PhaRMA(SM) Senior Secured Notes due 2015 (the "Notes") in a non-registered offering pursuant to Rule 144A. The Notes bear an interest rate of 10.25%. The royalties and other payments, if any, that QHP will be entitled to receive under the agreements with Genentech, together with any funds made available from certain accounts of QHP, will be the sole source of payment of principal of, and interest and premium on, the Notes, which are secured by a continuing security interest granted by QHP in its rights to receive payments under such agreements and all of its other assets and a pledge by PDL of its equity ownership interest in QHP. The Notes may be redeemed at any time prior to maturity, in whole or in part, at the option of QHP at a make-whole redemption price.

PDL intends to use a sizable portion of the net offer
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
2. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
3. Helix BioPharma Corp. Announces Fiscal 2009 Results
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
9. PDL BioPharma Completes October 1 Special Dividend Payment
10. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
11. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... announced today the award recipients from its November ... of the March of Dimes, National Prematurity Awareness ... voting for their preferred Neonatal Intensive Care Unit. ... in neonatal human milk support products from Medela: ... ,, * St. John Medical Center, Tulsa, OK. ...
(Date:12/17/2009)... Dec. 17 CANTEL MEDICAL CORP. ... Board of Directors intends to pay, for the first ... share, or $0.10 per share annually, on the Company,s ... of $0.05 per share of outstanding common stock, to ... record at the close of business on January 15, ...
(Date:12/17/2009)... NEW YORK, Dec. 17 Duane Reade, the ... announced plans for its H1N1 immunization program as part ... wellness needs of New Yorkers and to be a ... immunization vaccines will be offered at select Duane Reade ... the H1N1 vaccine by the New York City Department ...
Breaking Medicine Technology:Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2009 Prematurity Awareness Month 2Cantel Medical Authorizes Semiannual Dividend 2Duane Reade Announces Plans for H1N1 Immunization Program 2Duane Reade Announces Plans for H1N1 Immunization Program 3Press Ganey Launches Community Image Solution 50480 1Press Ganey Launches Community Image Solution 50480 2Press Ganey Launches Community Image Solution 50480 3Triggering muscle development a therapeutic cure for muscle wastage 3F 9077 1FDA Panel Urges Ban on Vicodin Percocet 50476 1FDA Panel Urges Ban on Vicodin Percocet 50476 2FDA Panel Urges Ban on Vicodin Percocet 50476 3FDA Panel Urges Ban on Vicodin Percocet 50476 4
... March 7 The,Journal of the American College of ... (Deferral Versus Performance of PTCA in,Patients Without Documented Ischemia) ... on cardiology in 2007, according to an article entitled,"Highlights ... MD, et al. (JACC,Vol. 51, No. 4, 2008 January ...
... Study Seeks Treatment to Address Skin Hardening Affects ... Physicians at Northwestern,Memorial Hospital are studying the effects ... a rare, incurable autoimmune rheumatic disease,that leads to ... tissues.,Scleroderma affects an estimated 300,000 people in the ...
Other Medicine Technology:JACC Identifies DEFER with 5-year Outcomes as Landmark Trial 2Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients 2
(Date:12/17/2009)... Samaritan Hospital is changing the way women manage their ... the Good Samaritan Hospital Women,s Center For Bladder & ... treat two common medical problems - lack of bladder ... or rectum (pelvic organ prolapse). Three out of four ... out of three may experience pelvic organ prolapse, but ...
(Date:12/17/2009)... 17, 2009 Canadian teenagers are among the largest ... illicit drug on young brains are worse than originally ... a psychiatric researcher from the Research Institute of the ... Neurobiology of Disease , suggests that daily consumption ... and have an irreversible long-term effect on the brain. ...
(Date:12/17/2009)... someday ease accompanying lung infections , , THURSDAY, Dec. 17 ... infected with the swine flu virus, and researchers say ... key to the severity of the illness appears to ... the immune system fight off germs and disease. Researchers ... at 10 Spanish hospitals last summer found the highest ...
(Date:12/17/2009)... studies examining radiation doses delivered during computed tomography examinations ... play in minimizing dose and protecting patients, according to ... ... Albuquerque, NM (Vocus) December ... delivered during computed tomography examinations underscore the important role ...
(Date:12/17/2009)... 17 CareTech Solutions ( www.CareTech.com ), an ... for hospitals and health systems, was named Best in ... 2009 Top 20 Best in KLAS Awards: Software ... ranks the performance of vendors in key market segments ... ,, CareTech,s overall performance score was 90.3 ...
Breaking Medicine News(10 mins):Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3
... ALEXANDRIA, Va., Feb. 4 The President,Medicine & ... PhD,issued the following statement in response to the ... which would continue to,under-fund diabetes research and prevention ... Centers for Disease Control and Prevention (CDC).,Under the ...
... GOLDEN, Colo., Feb. 4 ABR-Affinity,BioReagents, a leading ... and exclusive supplier to Thermo Fisher Scientific, once,again ... Sales,Meeting and Supplier Expo, held January 11 - ... in San Antonio, Texas. With an emphasis on,"Blazing ...
... toy magnets pose almost-fatal attractions when swallowed by kids, new ... is the story of a little boy who swallowed a ... Eberle, 4, of San Jose, Calif., swallowed two tiny magnets ... last spring. , After the first ingestion, he confessed to ...
... PS3(R) Users Support Research Efforts of Parkinson,s, Alzheimer,s and ... Certain ... Computer Entertainment,Inc. (SCEI) today announced that since PLAYSTATION(R)3 (PS3(R)) took part,in ... registered users has reached over one million users. This,equates to roughly ...
... Caused by Tobacco,Use in Kentucky, FRANKFORT, Ky., Feb. ... (Helping Overcome Tobacco) will,gather at 10:30 am, Tuesday, February ... of tobacco use in the Commonwealth. The youth will,display ... Capitol, representing the,number of Kentuckians who die each month ...
... colleagues have a pretty good idea why your husband or ... imaging study, the Stanford University School of Medicine researchers have ... feelings is more activated in men than women during video-game ... are more attracted to, and more likely to become ,hooked, ...
Other Medicine News:Health News:Statement of the American Diabetes Association on the Administration's Proposal to Undermine Funds for Research, Prevention and Treatment in FY09 2Health News:ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas 2Health News:Toy Magnets Can be a Very Real Threat 2Health News:Toy Magnets Can be a Very Real Threat 3Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 2Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 3Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 2Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 3
... is intended for use in the clinical ... known concentration for monitoring assay conditions in ... Control with patient serum specimens when assaying ... user can compare observations with expected ranges ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
... test is a rapid chromatographic immunoassay for ... A and B viral antigens from nasopharyngeal ... The Directigen EZ Flu A+B test is ... viral antigens can be distinguished from influenza ...
Medicine Products: